Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma
Clinical trial NCT00059904 · COMPLETED
Trial details
- NCT number
- NCT00059904
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.